Evolution Clinical Trials, Inc | Hialeah Gardens, FL
Status and phase
Conditions
Treatments
About
This is a randomized, blinded, placebo-controlled study of BOS-580 in obese participants at risk for, or with biopsy-confirmed, nonalcoholic steatohepatitis (NASH), with a single arm open-label extension. It includes Parts A, B, C and D.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria (Part A and Part B):
Inclusion Criteria (Part C):
Inclusion Criteria (Part D):
Exclusion Criteria (Part A and Part B):
Exclusion Criteria (Part C):
• Participants that received their 24 week dose in Part B > 10 weeks prior to enrollment into Part C
Exclusion Criteria (Part D):
Primary purpose
Allocation
Interventional model
Masking
231 participants in 9 patient groups
Loading...
Central trial contact
Study Medical Director
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal